A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 2,588,585 shares of BMY stock, worth $108 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,588,585
Previous 2,635,904 1.8%
Holding current value
$108 Million
Previous $135 Million 3.79%
% of portfolio
0.32%
Previous 0.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $2.27 Million - $2.57 Million
-47,319 Reduced 1.8%
2,588,585 $140 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $5.33 Million - $6.36 Million
-109,887 Reduced 4.0%
2,635,904 $135 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $4.3 Million - $4.8 Million
-74,215 Reduced 2.63%
2,745,791 $159 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $15.6 Million - $17.3 Million
245,172 Added 9.52%
2,820,006 $180 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $22.3 Million - $25.3 Million
339,209 Added 15.17%
2,574,834 $178 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $14.2 Million - $16.8 Million
207,405 Added 10.23%
2,235,625 $161 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $7,457 - $4.41 Million
-57,369 Reduced 2.75%
2,028,220 $144 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $50 Million - $55.1 Million
688,663 Added 49.3%
2,085,589 $161 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $481,019 - $576,785
-7,824 Reduced 0.56%
1,396,926 $102 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $3.36 Million - $3.92 Million
-62,632 Reduced 4.27%
1,404,750 $87.6 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $1.91 Million - $2.24 Million
-32,310 Reduced 2.15%
1,467,382 $86.8 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $8.53 Million - $9.28 Million
-137,705 Reduced 8.41%
1,499,692 $100 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $18.9 Million - $21.3 Million
-318,609 Reduced 16.29%
1,637,397 $103 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $7.23 Million - $8.19 Million
-125,232 Reduced 6.02%
1,956,006 $121 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $11 Million - $12.2 Million
-192,285 Reduced 8.46%
2,081,238 $125 Million
Q2 2020

Sep 11, 2020

BUY
$54.82 - $64.09 $15.2 Million - $17.8 Million
277,885 Added 13.92%
2,273,523 $134 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $32.5 Million - $38 Million
-593,315 Reduced 22.92%
1,995,638 $134 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $5.89 Million - $8.56 Million
126,953 Added 5.16%
2,588,953 $144 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $33 Million - $43 Million
670,542 Added 37.43%
2,462,000 $158 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $4.41 Million - $5.23 Million
103,053 Added 6.1%
1,791,458 $90 Million
Q2 2019

Aug 07, 2019

BUY
$44.62 - $49.34 $8.93 Million - $9.87 Million
200,045 Added 13.44%
1,688,405 $76.1 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $1.97 Million - $2.34 Million
43,561 Added 3.02%
1,488,360 $71.2 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $2.02 Million - $2.62 Million
41,448 Added 2.95%
1,444,799 $75.1 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $114 Million - $128 Million
-2,064,008 Reduced 59.53%
1,403,351 $87.1 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $3.45 Million - $4.3 Million
68,236 Added 2.01%
3,467,359 $192 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $1.43 Million - $1.65 Million
23,876 Added 0.71%
3,399,123 $215 Million
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $764,594 - $833,604
-12,756 Reduced 0.38%
3,375,247 $207 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $187 Million - $216 Million
3,388,003
3,388,003 $216 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.